Viewing nowGlipensupreme Tablets (Fenofibrate)
Fenofibrate 160mg
Tablet · Prescription medication
Samchundang Pharm Co., Ltd.

MFDS item code 200702596 · Notified 2007.03.02 · Insurance code 651200040
Improvement of primary hyperlipidemia (hypercholesterolemia, hypertriglyceridemia)
This medication is used for various lipid abnormalities in the blood, including primary hyperlipidemia, specifically hypercholesterolemia and hypertriglyceridemia. It helps improve type IIa hypercholesterolemia, combined types of hypercholesterolemia and hypertriglyceridemia (type IIb, type III), and hypertriglyceridemia (type IV). Through this treatment, it can regulate blood lipid levels and reduce the risk of cardiovascular diseases. Thus, this medication is effectively used in the treatment of lipid disorders.
As fenofibrate, take 160 mg orally once daily immediately after a meal. This medication must be administered in conjunction with dietary therapy. Absorption may be reduced if taken on an empty stomach, so it should be taken immediately after meals.
There is currently no clinical data regarding the use of this medication in children.
This medicine should not be used in patients with poor liver function. It should not be administered to patients with moderate to severe kidney dysfunction due to the risk of rhabdomyolysis, which can cause serious muscle damage. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. Patients allergic to this medicine or its components should also refrain from taking it. Patients with gallbladder diseases or gallstones should use caution, as this medication may worsen gallstones. Patients who have experienced photosensitivity reactions while using fibrates or ketoprofen should not be administered this medicine. Children cannot take this medication. Patients with lactose intolerance or specific genetic metabolic disorders should also avoid this medication. Patients allergic to soybean oil, soybeans, or peanuts should refrain from using this medication. Caution is advised for patients with mild kidney impairment or liver dysfunction; dosing should be adjusted and intervals increased as necessary. Patients with blood coagulation disorders or those taking anticoagulants should be vigilant due to the risk of bleeding. Regular monitoring of liver function tests and blood lipid levels is required during the course of this treatment, and adjustments or cessation should be made if abnormalities are found. Rashes, itching, and photosensitivity reactions may occur on the skin, so it is advisable to avoid sun exposure. If symptoms such as muscle pain, cramps, or weakness occur, immediate consultation with a physician is necessary, and in severe cases, discontinuation of the medication is required. Regular blood tests are necessary as there may be a decrease in blood cell counts or abnormalities in liver and kidney functions. This medication may interact with other drugs, especially statins, anticoagulants, and hypoglycemic agents, so caution is necessary when co-administered. There is no specific antidote for overdose, so the prescribed dosage must be strictly followed. It should be kept out of the reach of children, and it is safe not to transfer it to another container.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, severe rash accompanied by high fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty in breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice (yellowing of the skin or eyes), extreme lethargy, sudden and severe headaches, lightning headache, seizures, confusion of consciousness, vision disturbances, paralysis, urination changes
Increased serum aminotransferase levels, liver enlargement, cholestatic hepatitis, gallstones, rash, itching, photosensitivity reactions, hair loss, weakness, fever, dizziness, headache, peripheral neuropathy, thromboembolism, elevated creatine kinase (CK), muscle pain, cramps, joint pain, gastrointestinal disturbances (abdominal pain, nausea, vomiting, diarrhea, abdominal bloating), pancreatitis, hepatic impairment, hemoglobin decrease, leukopenia, eosinophilia, serum creatinine
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius.
White rectangular film-coated tablet
100 tablets/box [(10 tablets/PTP x 10)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowFenofibrate 160mg
Tablet · Prescription medication
Samchundang Pharm Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Yu Yeong Pharmaceutical Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Kyung Dong Pharmaceutical Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Dongkook Pharmaceutical Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Korea Hyutecs Pharmaceutical Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Aju Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.